- Home
- SRBK vs INMB Comparison
SRBK vs INMB Comparison
Compare SRBK & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.53
Company Overview
Basic Information| Metric | SRBK | INMB |
|---|---|---|
| Founded | 1887 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.8M | 64.7M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SRBK | INMB |
|---|---|---|
| Price | $18.83 | $1.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 20.6K | ★ 277.0K |
| Earning Date | 11-02-2026 | 11-02-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ 0.44 | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.23 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $14.60 | $1.09 |
| 52 Week High | $20.95 | $2.60 |
Technical Indicators
Market Signals| Indicator | SRBK | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 30.43 |
| Support Level | $18.62 | $1.34 |
| Resistance Level | $19.07 | $1.76 |
| Average True Range (ATR) | 0.38 | 0.12 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 91.79 | 2.40 |
Price Performance
Historical Comparison SRBK
INMB
About SRBK SR Bancorp Inc.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.